De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Applied Molecular Transport Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Shawn Cross
Algemeen directeur
US$1.7m
Totale compensatie
| Percentage CEO-salaris | 27.7% |
| Dienstverband CEO | less than a year |
| Eigendom CEO | 0.2% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 2.1yrs |
Recente managementupdates
Recent updates
Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Mar 07
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Nov 13Applied Molecular Transport GAAP EPS of -$0.93
Aug 04Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky
Jul 27Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data
Jul 05Applied Molecular: Interesting Drug Delivery Approach For The GI Tract
May 03We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Apr 28We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Jan 08We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Aug 29Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans
Apr 05Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?
Feb 11Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Dec 21Applied Molecular Transport reports Q3 results
Nov 12Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$75m |
| Jun 30 2023 | n/a | n/a | -US$93m |
| Mar 31 2023 | n/a | n/a | -US$112m |
| Dec 31 2022 | US$2m | US$476k | -US$126m |
| Sep 30 2022 | n/a | n/a | -US$134m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$122m |
| Dec 31 2021 | US$3m | US$410k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$89m |
| Jun 30 2021 | n/a | n/a | -US$80m |
| Mar 31 2021 | n/a | n/a | -US$72m |
| Dec 31 2020 | US$2m | US$311k | -US$67m |
Compensatie versus markt: De totale vergoeding ($USD 1.72M ) Shawn } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 677.23K ).
Compensatie versus inkomsten: De vergoeding van Shawn is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Shawn Cross (55 yo)
less than a year
Tenure
US$1,717,813
Compensatie
Mr. Shawn M. Cross serves as Managing Director of Healthcare Investment Banking Group at Citizens JMP Securities, LLC (formerly known as JMP Securities LLC). He was Managing Director and Co-Head Healthcare...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Chairman | less than a year | US$1.72m | 0.17% $ 18.3k | |
| Co-Founder & Director | 7.1yrs | US$3.55m | 9.77% $ 1.1m | |
| Independent Director | 1.8yrs | US$394.26k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Director | 1.9yrs | US$429.94k | 0% $ 0 | |
| Independent Director | 7.1yrs | US$90.28k | 0.51% $ 55.9k | |
| Lead Independent Director | 2.3yrs | US$102.84k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens |
2.1yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van AMTI wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.1 jaar), wat duidt op een nieuw bestuur.